SV1997000035A - Acetilenos de biaril como inhibisores de matrices metaloproteasas - Google Patents
Acetilenos de biaril como inhibisores de matrices metaloproteasasInfo
- Publication number
- SV1997000035A SV1997000035A SV1997000035A SV1997000035A SV1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A
- Authority
- SV
- El Salvador
- Prior art keywords
- biaril
- metaloprotease
- acetylene
- matrix inhibitors
- matrix
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
EL PRESENTE INVENTO SE REFIERE A INHIBIDORES DE ENZIMAS Y MS ESPECIFICAMENTE, COM NOVEDOSOS COMPUESTOS QUE CONTIENEN BIARILACETILENO O DERIVADOS DE LOS MISMOS PARA INHIBIR LAS METALOSPROTEASAS. DE MATRIZ.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64502896A | 1996-05-15 | 1996-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV1997000035A true SV1997000035A (es) | 1999-01-14 |
Family
ID=24587368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV1997000035A SV1997000035A (es) | 1996-05-15 | 1997-05-12 | Acetilenos de biaril como inhibisores de matrices metaloproteasas |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0912496A1 (es) |
JP (1) | JP3090957B2 (es) |
CN (1) | CN1139570C (es) |
AR (1) | AR007097A1 (es) |
AU (1) | AU710759B2 (es) |
BR (1) | BR9709077A (es) |
CA (1) | CA2253796C (es) |
CO (1) | CO5080759A1 (es) |
HN (1) | HN1997000088A (es) |
HR (1) | HRP970245B1 (es) |
ID (1) | ID16910A (es) |
PA (1) | PA8429301A1 (es) |
SV (1) | SV1997000035A (es) |
TN (1) | TNSN97084A1 (es) |
TW (1) | TW381079B (es) |
WO (1) | WO1997043245A1 (es) |
YU (1) | YU18697A (es) |
ZA (1) | ZA974031B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6288063B1 (en) | 1998-05-27 | 2001-09-11 | Bayer Corporation | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
AR035478A1 (es) * | 1999-01-27 | 2004-06-02 | Wyeth Corp | Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene |
US6326516B1 (en) | 1999-01-27 | 2001-12-04 | American Cyanamid Company | Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors |
EP1031349A1 (en) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
HUE030114T2 (en) | 2010-07-08 | 2017-04-28 | Kaken Pharma Co Ltd | N-hydroxyformamide derivatives and pharmaceutical compositions containing them |
US20170022171A1 (en) | 2014-04-03 | 2017-01-26 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentanecarboxylic acids and their use |
CN106458938A (zh) | 2014-04-03 | 2017-02-22 | 拜耳制药股份公司 | 手性2,5‑二取代的环戊烷甲酸衍生物及其用途 |
US20170114049A1 (en) | 2014-04-03 | 2017-04-27 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3784701A (en) * | 1970-09-21 | 1974-01-08 | American Cyanamid Co | Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain |
DE2112716A1 (de) * | 1971-03-17 | 1972-10-05 | Thomae Gmbh Dr K | Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester |
US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
-
1997
- 1997-05-09 TN TNTNSN97084A patent/TNSN97084A1/fr unknown
- 1997-05-09 ZA ZA9704031A patent/ZA974031B/xx unknown
- 1997-05-09 HR HR970245A patent/HRP970245B1/xx not_active IP Right Cessation
- 1997-05-09 CO CO97025172A patent/CO5080759A1/es unknown
- 1997-05-12 TW TW086106283A patent/TW381079B/zh not_active IP Right Cessation
- 1997-05-12 HN HN1997000088A patent/HN1997000088A/es unknown
- 1997-05-12 BR BR9709077A patent/BR9709077A/pt not_active Application Discontinuation
- 1997-05-12 JP JP09540980A patent/JP3090957B2/ja not_active Expired - Fee Related
- 1997-05-12 AR ARP970101977A patent/AR007097A1/es unknown
- 1997-05-12 CA CA002253796A patent/CA2253796C/en not_active Expired - Fee Related
- 1997-05-12 SV SV1997000035A patent/SV1997000035A/es unknown
- 1997-05-12 WO PCT/US1997/007921 patent/WO1997043245A1/en not_active Application Discontinuation
- 1997-05-12 YU YU18697A patent/YU18697A/sr unknown
- 1997-05-12 PA PA19978429301A patent/PA8429301A1/es unknown
- 1997-05-12 EP EP97923622A patent/EP0912496A1/en not_active Withdrawn
- 1997-05-12 AU AU29386/97A patent/AU710759B2/en not_active Ceased
- 1997-05-12 CN CNB971964564A patent/CN1139570C/zh not_active Expired - Fee Related
- 1997-05-14 ID IDP971606A patent/ID16910A/id unknown
Also Published As
Publication number | Publication date |
---|---|
AU710759B2 (en) | 1999-09-30 |
JPH11511179A (ja) | 1999-09-28 |
CN1225623A (zh) | 1999-08-11 |
BR9709077A (pt) | 1999-08-03 |
ID16910A (id) | 1997-11-20 |
TNSN97084A1 (fr) | 2005-03-15 |
TW381079B (en) | 2000-02-01 |
WO1997043245A1 (en) | 1997-11-20 |
AU2938697A (en) | 1997-12-05 |
CA2253796A1 (en) | 1997-11-20 |
ZA974031B (en) | 1998-02-19 |
JP3090957B2 (ja) | 2000-09-25 |
EP0912496A1 (en) | 1999-05-06 |
PA8429301A1 (es) | 2000-05-24 |
CO5080759A1 (es) | 2001-09-25 |
YU18697A (en) | 1999-11-22 |
AR007097A1 (es) | 1999-10-13 |
HRP970245A2 (en) | 1998-04-30 |
HN1997000088A (es) | 1997-06-18 |
HRP970245B1 (en) | 2002-06-30 |
CN1139570C (zh) | 2004-02-25 |
CA2253796C (en) | 2003-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2196630T3 (es) | Isotiazolcarboxiamidas y su empleo para la proteccion de las plantas. | |
ES2196502T3 (es) | Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas. | |
ES2175443T3 (es) | Compuestos de naptopirano y articulos que los contienen. | |
SV1996000026A (es) | Benzociclopentano oxazolidinonas que contienen heteroatomos | |
ES2179088T3 (es) | Inhibidores de flsa2 1h-indol-3-glioxilamida. | |
ES2196593T3 (es) | Productos de carbono modificados con grupos salientes para tintas y revestimientos. | |
SV1998000008A (es) | Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114 | |
PA8468401A1 (es) | Compuestos para el tratamiento de la isquemia | |
ES2164182T3 (es) | Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana. | |
ES2103152T3 (es) | Utilizacion de derivados de acido salicilico para la despigmentacion de la piel. | |
ES2184888T3 (es) | Empleo de catalizadores de estaño, asi como mezclas reticulables que contienen estos catalizadores. | |
HN1993004031A (es) | N - (4,6 dime) amin - 3 tri - 2 sulfo o una de sus sales utiles composicion herbicida que contiene el mismo y proceso para la produccion del compuesto. | |
HN1999000106A (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa. | |
SV1997000035A (es) | Acetilenos de biaril como inhibisores de matrices metaloproteasas | |
PA8577201A1 (es) | 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b | |
MX9307232A (es) | Arilcicloalquilaminas n,n-disustituidas, sus sales, medicamentos que contiene estos compuestos y su empleo, asi como procedimientos para su preparacion. | |
ES2074060T3 (es) | Nuevos ciano y alenil derivados de aristeromicina/adenosina acetilenicos. | |
ES2153748A1 (es) | Mezcla sinergica de estabilizadores a base de compuestos de polialquil-1-1-oxa-diaza-espirodecano. | |
GT199900011A (es) | Nuevos derivados del acido dihidroxihexanoico | |
ES2179138T3 (es) | Poliisocianatos que presentan grupos alofanato basados en difenilmetanodiisocianato con grupos isocianato predominante o completamente bloqueados. | |
ES2184126T3 (es) | Derivados de 3-mercaptoacetilamino-1,5-sustituido-2-oxo-azepan utiles como inhibidores de metaloproteinasas de la matriz. | |
MX9305093A (es) | Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa. | |
ATE68200T1 (de) | Antioxidanz-produkte. | |
GT199900113A (es) | Inhibidores de las fkbp. | |
MX9304152A (es) | Inhibidores de enzimas. |